Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TÓTH, T.
Right arrow Articles by TAKEBAYASHI, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TÓTH, T.
Right arrow Articles by TAKEBAYASHI, S.
J Am Soc Nephrol 10:1498-1505, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Mast Cells in Rapidly Progressive Glomerulonephritis

TIBOR TÓTH*, RIA TÓTH-JAKATICS*, SHIRO JIMI*, MAKOTO IHARA{dagger}, HIDENORI URATA{dagger} and SHIGEO TAKEBAYASHI*

* Second Department of Pathology, Fukuoka University, School of Medicine, Fukuoka, Japan.
{dagger} Department of Internal Medicine, Fukuoka University, School of Medicine, Fukuoka, Japan.

Correspondence to Dr. Tibor Tóth, The Second Department of Pathology, Fukuoka University, School of Medicine, Nanakuma 7-45-1, Jonan-ku, Fukuoka 814-0180, Japan. Phone: +81-92-801-1011; Fax: +81-92-863-8383; E-mail: mm038492{at}Msat.fukuoka-u.ac.jp

Abstract. The role of mast cells (MC) in tubulointerstitial damage in glomerulonephritis (GN) is not fully understood. The distribution of MC was compared in renal biopsies from 50 patients with different stages of rapidly progressive GN (RPGN) and in 20 control samples. The immunoreactivity of renal MC with anti-tryptase and anti-chymase antibodies was studied. Interstitial myofibroblasts were stained with anti-{alpha}-smooth muscle actin ({alpha}-SMA) antibody, and inflammatory cells were identified by anti-CD3, -CD20, and -CD68 monoclonal antibodies. Positively stained cells were counted, and the relative interstitial and fractional areas of anti-{alpha}-SMA-stained cells were measured. MC were rarely found in control samples. In contrast, samples showing crescentic GN contained numerous tryptase-positive MC (MCT) (43.7 ± 4.65 versus 7.14 ± 1.3/mm2) and fewer tryptase- and chymase-positive MC (MCTC) (13.8 ± 1.86 versus 1.89 ± 0.86/mm2) in the renal interstitium but never in the glomerulus. Double immunostaining demonstrated the presence of both phenotypes of MC. Accumulation of MC was significantly correlated with the numbers of T lymphocytes (MCT, r = 0.67) and interstitial macrophages (MCT, r = 0.455). There was also a significant correlation between the number of MCT and the relative interstitial area. The number of MCTC was well correlated with the fractional area of {alpha}-SMA-positive interstitium (r = 0.749) and the percentage of the interstitial fibrotic area (r = 0.598). There was also a significant negative correlation between interstitial MCTC accumulation and creatinine clearance (r = 0.661). The density of MCTC was higher (1.4-fold) in advanced forms of GN associated with fibrocellular crescents and interstitial fibrosis. These results show the potential involvement of MC in the fibroproliferative process in the renal interstitium of patients with RPGN. The results indicate that these cells constitute part of the overall inflammatory cell accumulation in RPGN.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. R. Holdsworth and S. A. Summers
Role of Mast Cells in Progressive Renal Diseases
J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2254 - 2261.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. R. Timoshanko, R. Kitching, T. J. Semple, P. G. Tipping, and S. R. Holdsworth
A Pathogenetic Role for Mast Cells in Experimental Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 150 - 159.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R C. Ravinal, R S Costa, T M Coimbra, M Dantas, and M A dos Reis
Mast cells, TGF-{beta}1 and myofibroblasts expression in lupus nephritis outcome
Lupus, October 1, 2005; 14(10): 814 - 821.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. A. McPherson, Z. Luo, R. A. Brown, L. S. LeBard, C. C. Corless, R. C. Speth, and S. P. Bagby
Chymase-like Angiotensin II-Generating Activity in End-Stage Human Autosomal Dominant Polycystic Kidney Disease
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 493 - 500.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Boyce, E. A. Mellor, B. Perkins, Y.-C. Lim, and F. W. Luscinskas
Human mast cell progenitors use alpha 4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions
Blood, April 15, 2002; 99(8): 2890 - 2896.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. KONDO, S. KAGAMI, H. KIDO, F. STRUTZ, G. A. MULLER, and Y. KURODA
Role of Mast Cell Tryptase in Renal Interstitial Fibrosis
J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1668 - 1676.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP